[English] 日本語
Yorodumi- EMDB-66899: SARS-CoV-2 Omicron BA.4/5 spike trimer in complex with BD56-597 F... -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | SARS-CoV-2 Omicron BA.4/5 spike trimer in complex with BD56-597 Fab and ACE2 (3 RBD up) | |||||||||||||||||||||||||||
Map data | ||||||||||||||||||||||||||||
Sample |
| |||||||||||||||||||||||||||
Keywords | Spike protein / Antibody Fab fragment / Complex / VIRAL PROTEIN/IMMUNE SYSTEM/HYDROLASE / VIRAL PROTEIN-IMMUNE SYSTEM-HYDROLASE complex | |||||||||||||||||||||||||||
| Function / homology | Function and homology informationpositive regulation of amino acid transport / angiotensin-converting enzyme 2 / positive regulation of L-proline import across plasma membrane / Hydrolases; Acting on peptide bonds (peptidases); Metallocarboxypeptidases / angiotensin-mediated drinking behavior / positive regulation of gap junction assembly / tryptophan transport / regulation of systemic arterial blood pressure by renin-angiotensin / maternal process involved in female pregnancy / regulation of cardiac conduction ...positive regulation of amino acid transport / angiotensin-converting enzyme 2 / positive regulation of L-proline import across plasma membrane / Hydrolases; Acting on peptide bonds (peptidases); Metallocarboxypeptidases / angiotensin-mediated drinking behavior / positive regulation of gap junction assembly / tryptophan transport / regulation of systemic arterial blood pressure by renin-angiotensin / maternal process involved in female pregnancy / regulation of cardiac conduction / carboxypeptidase activity / transporter activator activity / peptidyl-dipeptidase activity / amino acid import across plasma membrane / regulation of vasoconstriction / Metabolism of Angiotensinogen to Angiotensins / receptor-mediated endocytosis of virus by host cell / angiotensin maturation / viral life cycle / transmembrane transporter complex / Attachment and Entry / metallocarboxypeptidase activity / positive regulation of cardiac muscle contraction / regulation of cytokine production / blood vessel diameter maintenance / negative regulation of smooth muscle cell proliferation / brush border membrane / negative regulation of ERK1 and ERK2 cascade / virus receptor activity / positive regulation of reactive oxygen species metabolic process / metallopeptidase activity / endocytic vesicle membrane / cilium / regulation of cell population proliferation / regulation of inflammatory response / symbiont-mediated disruption of host tissue / Maturation of spike protein / endopeptidase activity / host cell surface / Translation of Structural Proteins / Virion Assembly and Release / Lectin pathway of complement activation / host extracellular region / symbiont-mediated-mediated suppression of host tetherin activity / structural constituent of virion / Induction of Cell-Cell Fusion / Potential therapeutics for SARS / positive regulation of viral entry into host cell / Initial triggering of complement / membrane fusion / host cell endoplasmic reticulum-Golgi intermediate compartment membrane / Attachment and Entry / entry receptor-mediated virion attachment to host cell / receptor-mediated virion attachment to host cell / host cell surface receptor binding / symbiont-mediated suppression of host innate immune response / apical plasma membrane / endocytosis involved in viral entry into host cell / membrane raft / receptor ligand activity / endoplasmic reticulum lumen / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / symbiont entry into host cell / virion attachment to host cell / host cell plasma membrane / SARS-CoV-2 activates/modulates innate and adaptive immune responses / virion membrane / negative regulation of transcription by RNA polymerase II / cell surface / extracellular exosome / zinc ion binding / extracellular region / membrane / identical protein binding / plasma membrane / cytoplasm Similarity search - Function | |||||||||||||||||||||||||||
| Biological species | ![]() Homo sapiens (human) | |||||||||||||||||||||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.22 Å | |||||||||||||||||||||||||||
Authors | Niu C / Liu B / Gao X / Li Z / He J / Xiong X | |||||||||||||||||||||||||||
| Funding support | China, 8 items
| |||||||||||||||||||||||||||
Citation | Journal: To Be PublishedTitle: AI identifies Elite Antibodies that Tolerate Escape Mutations from a Population Antibody Class Exerting Continued Selection Over SARS-CoV-2 Authors: Niu C / Huang X / Yan Q / Liu B / Gao X / Song Y / Wang J / Wang L / Li Z / Zheng H / He P / Huang X / Yuan H / Zou B / Yang Y / Wu F / Yao Y / Chen X / Chen L / He J / Yao J / Zhao J / Xiong X | |||||||||||||||||||||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_66899.map.gz | 362.9 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-66899-v30.xml emd-66899.xml | 22.8 KB 22.8 KB | Display Display | EMDB header |
| Images | emd_66899.png | 36.4 KB | ||
| Filedesc metadata | emd-66899.cif.gz | 7.7 KB | ||
| Others | emd_66899_half_map_1.map.gz emd_66899_half_map_2.map.gz | 676.3 MB 676.3 MB | ||
| Archive directory | https://data.pdbj.org/pub/emdb/structures/EMD-66899 ftp://data.pdbj.org/pub/emdb/structures/EMD-66899 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9xi7MC ![]() 9xhyC ![]() 9xhzC ![]() 9xi0C ![]() 9xi1C ![]() 9xi2C ![]() 9xi3C ![]() 9xi4C ![]() 9xi5C ![]() 9xi6C ![]() 9xi8C ![]() 9xi9C M: atomic model generated by this map C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_66899.map.gz / Format: CCP4 / Size: 729 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.732 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: #1
| File | emd_66899_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: #2
| File | emd_66899_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : SARS-CoV-2 Omicron BA.4/5 spike trimer in complex with BD56-597 F...
| Entire | Name: SARS-CoV-2 Omicron BA.4/5 spike trimer in complex with BD56-597 Fab and ACE2 (3 RBD up) |
|---|---|
| Components |
|
-Supramolecule #1: SARS-CoV-2 Omicron BA.4/5 spike trimer in complex with BD56-597 F...
| Supramolecule | Name: SARS-CoV-2 Omicron BA.4/5 spike trimer in complex with BD56-597 Fab and ACE2 (3 RBD up) type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#4 |
|---|---|
| Source (natural) | Organism: ![]() |
-Macromolecule #1: Spike glycoprotein
| Macromolecule | Name: Spike glycoprotein / type: protein_or_peptide / ID: 1 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() |
| Molecular weight | Theoretical: 138.648734 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: QCVNLITRTQ LPPSYTNSFT RGVYYPDKVF RSSVLHSTQD LFLPFFSNVT WFHAIHVSGT NGTKRFDNPV LPFNDGVYFA STEKSNIIR GWIFGTTLDS KTQSLLIVNN ATNVVIKVCE FQFCNDPFLD VYYHKNNKSW MESEFRVYSS ANNCTFEYVS Q PFLMDLEG ...String: QCVNLITRTQ LPPSYTNSFT RGVYYPDKVF RSSVLHSTQD LFLPFFSNVT WFHAIHVSGT NGTKRFDNPV LPFNDGVYFA STEKSNIIR GWIFGTTLDS KTQSLLIVNN ATNVVIKVCE FQFCNDPFLD VYYHKNNKSW MESEFRVYSS ANNCTFEYVS Q PFLMDLEG KQGNFKNLRE FVFKNIDGYF KIYSKHTPIN LGRDLPQGFS ALEPLVDLPI GINITRFQTL LALHRSYLTP GD SSSGWTA GAAAYYVGYL QPRTFLLKYN ENGTITDAVD CALDPLSETK CTLKSFTVEK GIYQTSNFRV QPTESIVRFP NIT NLCPFD EVFNATRFAS VYAWNRKRIS NCVADYSVLY NFAPFFAFKC YGVSPTKLND LCFTNVYADS FVIRGNEVSQ IAPG QTGNI ADYNYKLPDD FTGCVIAWNS NKLDSKVGGN YNYRYRLFRK SNLKPFERDI STEIYQAGNK PCNGVAGVNC YFPLQ SYGF RPTYGVGHQP YRVVVLSFEL LHAPATVCGP KKSTNLVKNK CVNFNFNGLT GTGVLTESNK KFLPFQQFGR DIADTT DAV RDPQTLEILD ITPCSFGGVS VITPGTNTSN QVAVLYQGVN CTEVPVAIHA DQLTPTWRVY STGSNVFQTR AGCLIGA EY VNNSYECDIP IGAGICASYQ TQTKSPRRAR SVASQSIIAY TMSLGAENSV AYSNNSIAIP TNFTISVTTE ILPVSMTK T SVDCTMYICG DSTECSNLLL QYGSFCTQLK RALTGIAVEQ DKNTQEVFAQ VKQIYKTPPI KYFGGFNFSQ ILPDPSKPS KRSPIEDLLF NKVTLADAGF IKQYGDCLGD IAARDLICAQ KFNGLTVLPP LLTDEMIAQY TSALLAGTIT SGWTFGAGPA LQIPFPMQM AYRFNGIGVT QNVLYENQKL IANQFNSAIG KIQDSLSSTP SALGKLQDVV NHNAQALNTL VKQLSSKFGA I SSVLNDIL SRLDPPEAEV QIDRLITGRL QSLQTYVTQQ LIRAAEIRAS ANLAATKMSE CVLGQSKRVD FCGKGYHLMS FP QSAPHGV VFLHVTYVPA QEKNFTTAPA ICHDGKAHFP REGVFVSNGT HWFVTQRNFY EPQIITTDNT FVSGNCDVVI GIV NNTVYD PLQPELDSFK EELDKYFKNH TSPDVDLGDI SGINASVVNI QKEIDRLNEV AKNLNESLID LQELGKYEQY IKGS GRENL YFQGGGGSGY IPEAPRDGQA YVRKDGEWVL LSTFLGHHHH HH UniProtKB: Spike glycoprotein |
-Macromolecule #2: Processed angiotensin-converting enzyme 2
| Macromolecule | Name: Processed angiotensin-converting enzyme 2 / type: protein_or_peptide / ID: 2 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 69.717391 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: STIEEQAKTF LDKFNHEAED LFYQSSLASW NYNTNITEEN VQNMNNAGDK WSAFLKEQST LAQMYPLQEI QNLTVKLQLQ ALQQNGSSV LSEDKSKRLN TILNTMSTIY STGKVCNPDN PQECLLLEPG LNEIMANSLD YNERLWAWES WRSEVGKQLR P LYEEYVVL ...String: STIEEQAKTF LDKFNHEAED LFYQSSLASW NYNTNITEEN VQNMNNAGDK WSAFLKEQST LAQMYPLQEI QNLTVKLQLQ ALQQNGSSV LSEDKSKRLN TILNTMSTIY STGKVCNPDN PQECLLLEPG LNEIMANSLD YNERLWAWES WRSEVGKQLR P LYEEYVVL KNEMARANHY EDYGDYWRGD YEVNGVDGYD YSRGQLIEDV EHTFEEIKPL YEHLHAYVRA KLMNAYPSYI SP IGCLPAH LLGDMWGRFW TNLYSLTVPF GQKPNIDVTD AMVDQAWDAQ RIFKEAEKFF VSVGLPNMTQ GFWENSMLTD PGN VQKAVC HPTAWDLGKG DFRILMCTKV TMDDFLTAHH EMGHIQYDMA YAAQPFLLRN GANEGFHEAV GEIMSLSAAT PKHL KSIGL LSPDFQEDNE TEINFLLKQA LTIVGTLPFT YMLEKWRWMV FKGEIPKDQW MKKWWEMKRE IVGVVEPVPH DETYC DPAS LFHVSNDYSF IRYYTRTLYQ FQFQEALCQA AKHEGPLHKC DISNSTEAGQ KLFNMLRLGK SEPWTLALEN VVGAKN MNV RPLLNYFEPL FTWLKDQNKN SFVGWSTDWS PYADPLVPR UniProtKB: Angiotensin-converting enzyme 2 |
-Macromolecule #3: Heavy chain of BD56-597 Fab
| Macromolecule | Name: Heavy chain of BD56-597 Fab / type: protein_or_peptide / ID: 3 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 24.020895 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: QVQLVQSGAE VKKPGSSVKV SCKASGGTFS TYPISWVRQA PGQGVEWMGA IIPILGTTDY AQIFQGRVTI TADKSTSTAY MELSSLRPE DTAVYYCARE RGYSGYGAAY YFDSWGQGTL VTVSSASTKG PSVFPLAPSS KSTSGGTAAL GCLVKDYFPE P VTVSWNSG ...String: QVQLVQSGAE VKKPGSSVKV SCKASGGTFS TYPISWVRQA PGQGVEWMGA IIPILGTTDY AQIFQGRVTI TADKSTSTAY MELSSLRPE DTAVYYCARE RGYSGYGAAY YFDSWGQGTL VTVSSASTKG PSVFPLAPSS KSTSGGTAAL GCLVKDYFPE P VTVSWNSG ALTSGVHTFP AVLQSSGLYS LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD |
-Macromolecule #4: Light chain of BD56-597 Fab
| Macromolecule | Name: Light chain of BD56-597 Fab / type: protein_or_peptide / ID: 4 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 22.824229 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: QSVLTQPPSV SGAPGQRVTI SCTGSDSNIG AGYDVHWYQQ LPGTAPKLLI YVNINRPSGV PDRFSGSKSA TSASLAITGL QAEDEADYY CQSYDSSLSG VVFGGGTKLT VLGQPKAAPS VTLFPPSSEE LQANKATLVC LISDFYPGAV TVAWKADSSP V KAGVETTT ...String: QSVLTQPPSV SGAPGQRVTI SCTGSDSNIG AGYDVHWYQQ LPGTAPKLLI YVNINRPSGV PDRFSGSKSA TSASLAITGL QAEDEADYY CQSYDSSLSG VVFGGGTKLT VLGQPKAAPS VTLFPPSSEE LQANKATLVC LISDFYPGAV TVAWKADSSP V KAGVETTT PSKQSNNKYA ASSYLSLTPE QWKSHRSYSC QVTHEGSTVE KTVAPTECS |
-Macromolecule #6: 2-acetamido-2-deoxy-beta-D-glucopyranose
| Macromolecule | Name: 2-acetamido-2-deoxy-beta-D-glucopyranose / type: ligand / ID: 6 / Number of copies: 36 / Formula: NAG |
|---|---|
| Molecular weight | Theoretical: 221.208 Da |
| Chemical component information | ![]() ChemComp-NAG: |
-Macromolecule #7: ZINC ION
| Macromolecule | Name: ZINC ION / type: ligand / ID: 7 / Number of copies: 3 / Formula: ZN |
|---|---|
| Molecular weight | Theoretical: 65.409 Da |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Buffer | pH: 8 |
|---|---|
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 295 K |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Image recording | Film or detector model: TFS FALCON 4i (4k x 4k) / Average electron dose: 50.0 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.0 µm / Nominal defocus min: 0.6 µm |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi



Keywords
Homo sapiens (human)
Authors
China, 8 items
Citation





























Z (Sec.)
Y (Row.)
X (Col.)





































Processing
FIELD EMISSION GUN

